90 Questions
Which of the following is the most common site of hypertrophy in Hypertrophic Cardiomyopathy?
Left ventricle
What is the classic auscultatory finding for Hypertrophic Cardiomyopathy?
Crescendo-decrescendo systolic murmur along the left sternal border
What is the first-line treatment for symptomatic Hypertrophic Cardiomyopathy?
Beta blockers
What is the most common cause of sudden cardiac death in young adults with exertion?
Hypertrophic Cardiomyopathy
What is the prevalence of Hypertrophic Cardiomyopathy in the adult population?
1:500
Which imaging modality is the standard for diagnosis of Hypertrophic Cardiomyopathy?
Echocardiography
What is the most common age range for diagnosis of Hypertrophic Cardiomyopathy?
3rd decade
What is the highest incidence of sudden cardiac death in Hypertrophic Cardiomyopathy?
Preadolescent and adolescent children
What is the primary mechanism of sudden cardiac death in Hypertrophic Cardiomyopathy?
Ventricular fibrillation
What lifestyle modification is recommended for individuals with Hypertrophic Cardiomyopathy?
Avoidance of strenuous weightlifting
What is the key characteristic of restrictive cardiomyopathy?
Impaired ventricular filling
Which of the following is a common etiology of restrictive cardiomyopathy?
Amyloidosis
What percentage of all cardiomyopathies does restrictive cardiomyopathy account for?
5%
What is a typical presentation of restrictive cardiomyopathy?
Progressive shortness of breath
Which diagnostic test is not involved in the diagnosis of restrictive cardiomyopathy?
Lipid profile
What is the main goal of treatment for arrhythmogenic right ventricular dysplasia (ARVD)?
Prevent sustained ventricular arrhythmias and sudden death
What is the characteristic feature of stress cardiomyopathy (Takotsubo cardiomyopathy)?
Transient regional systolic dysfunction predominantly affecting the left ventricle
What triggers stress cardiomyopathy (Takotsubo cardiomyopathy)?
Intense emotional or physical stress
What is involved in the diagnosis of stress cardiomyopathy (Takotsubo cardiomyopathy)?
Echocardiogram
What is the main goal of treatment for stress cardiomyopathy (Takotsubo cardiomyopathy)?
Prevent sustained ventricular arrhythmias
What are the major types of cardiomyopathy?
Dilated, restrictive, hypertrophic, ARVD, and unclassified
What is the primary indication for cardiac transplantation?
Dilated cardiomyopathy
What are the risk factors for cardiomyopathy?
Family history, ischemic heart disease, diabetes, and long-term alcoholism
What are the symptoms of dilated cardiomyopathy?
Progressive dyspnea, impaired exercise tolerance, orthopnea, paroxysmal nocturnal dyspnea, and peripheral edema
What is the incidence of cardiomyopathy among heart failure patients in the US?
5-10%
What is the etiology of dilated cardiomyopathy?
Often unknown, with idiopathic cases comprising 50%, and myocarditis, ischemic heart disease, and other factors contributing to the rest
What are the treatment goals for cardiomyopathy?
To slow down the disease, control symptoms, and prevent sudden death
What is the prevalence of dilated cardiomyopathy?
36/100k
What can cardiomyopathy manifest as and progress to?
One form of cardiomyopathy and progress to another, such as hypertensive heart disease starting with a hypertrophic pattern and progressing to dilated cardiomyopathy
What is the epidemiology of dilated cardiomyopathy?
5-8/100k
Which of the following is a common presentation of Hypertrophic Cardiomyopathy?
Dyspnea on exertion (DOE)
What is the classic auscultatory finding for Hypertrophic Cardiomyopathy?
Crescendo-decrescendo systolic murmur along the left sternal border that increases with the valsalva maneuver
What is the most common site of hypertrophy in Hypertrophic Cardiomyopathy?
Interventricular septum
Which diagnostic test is considered the standard for the diagnosis of Hypertrophic Cardiomyopathy?
Echocardiography (ECHO)
What is the primary mechanism of sudden cardiac death in Hypertrophic Cardiomyopathy?
Lethal arrhythmia, such as ventricular fibrillation
What is the prevalence of Hypertrophic Cardiomyopathy in the adult population?
1:500
What lifestyle modification is recommended for individuals with Hypertrophic Cardiomyopathy?
Avoidance of strenuous weightlifting
What triggers sudden cardiac death in Hypertrophic Cardiomyopathy?
Exertion
What is the primary treatment for symptomatic Hypertrophic Cardiomyopathy?
Beta Blockers
What is the age range in which Hypertrophic Cardiomyopathy is most commonly diagnosed?
3rd decade
What is the prevalence of dilated cardiomyopathy?
36/100k
What is the characteristic feature of stress-induced cardiomyopathy?
Apical ballooning
What is the primary indication for cardiac transplantation in dilated cardiomyopathy?
Heart failure
What is the main goal of treatment for arrhythmogenic right ventricular dysplasia (ARVD)?
Prevention of sudden death
What is the main etiology of dilated cardiomyopathy?
Idiopathic causes
What is the characteristic presentation of hypertrophic cardiomyopathy?
Asymptomatic or with arrhythmias
What is the prevalence of hypertrophic cardiomyopathy in the adult population?
1 in 500
What are the major types of cardiomyopathy?
Dilated, restrictive, hypertrophic, arrhythmogenic right ventricular dysplasia, unclassified
What is the primary mechanism of sudden cardiac death in hypertrophic cardiomyopathy?
Arrhythmias
What are the risk factors for cardiomyopathy?
Hypertension, diabetes, substance abuse
Which cardiomyopathy is primarily characterized by non-dilated ventricles and impaired ventricular filling?
Restrictive cardiomyopathy
What is the primary cause of Arrhythmogenic Right Ventricular Dysplasia (ARVD)?
Genetic mutations
What is the mainstay treatment for restrictive cardiomyopathy?
Diuretics
Which cardiomyopathy affects about 1-2% of patients with suspected acute coronary syndrome, predominantly older women?
Stress cardiomyopathy (Takotsubo cardiomyopathy)
What is the characteristic feature of stress cardiomyopathy (Takotsubo cardiomyopathy)?
Transient regional systolic dysfunction
Which diagnostic test is primarily involved in the workup for Arrhythmogenic Right Ventricular Dysplasia (ARVD)?
EKG
What is the primary management strategy for Arrhythmogenic Right Ventricular Dysplasia (ARVD) to prevent sustained ventricular arrhythmias and sudden death?
Radiofrequency ablation
What is the prevalence of restrictive cardiomyopathy among all cardiomyopathies?
5%
What is the key characteristic of Arrhythmogenic Right Ventricular Dysplasia (ARVD)?
Right ventricular dysfunction
What is the primary goal of treatment for stress cardiomyopathy (Takotsubo cardiomyopathy)?
Managing underlying cause
What is the most common site of hypertrophy in Hypertrophic Cardiomyopathy?
Left ventricle, particularly the interventricular septum
What is the classic auscultatory finding for Hypertrophic Cardiomyopathy?
Crescendo-decrescendo systolic murmur along the left sternal border
What is the primary mechanism of sudden cardiac death in Hypertrophic Cardiomyopathy?
Arrhythmia
What is the most common age range for diagnosis of Hypertrophic Cardiomyopathy?
20-30 years
What is the primary diagnostic test for Hypertrophic Cardiomyopathy?
Echocardiography (ECHO)
What is the primary treatment for symptomatic Hypertrophic Cardiomyopathy?
Beta blockers
What is the prevalence of Hypertrophic Cardiomyopathy in the adult population?
1:500
What lifestyle modification is recommended for individuals with Hypertrophic Cardiomyopathy?
Avoidance of competitive athletics
What is the primary mechanism of sudden cardiac death in Hypertrophic Cardiomyopathy?
Arrhythmia
What are the symptoms of Hypertrophic Cardiomyopathy?
Dyspnea on exertion and chest pain with exertion
Which type of cardiomyopathy is primarily characterized by non-dilated ventricles and impaired ventricular filling?
Restrictive cardiomyopathy
What is the main etiology of arrhythmogenic right ventricular dysplasia (ARVD)?
Genetic factors
What lifestyle modification is recommended for individuals with hypertrophic cardiomyopathy?
Regular moderate exercise
What is the primary cause of dilated cardiomyopathy?
Idiopathic factors
What is the primary goal of treatment for arrhythmogenic right ventricular dysplasia (ARVD) to prevent sustained ventricular arrhythmias and sudden death?
Prevention of arrhythmias and sudden death
What is the prevalence of cardiomyopathy among heart failure patients in the US?
5-10%
What are the major types of genetic cardiomyopathies?
Hypertrophic and arrhythmogenic right ventricular dysplasia (ARVD)
What is the primary indication for cardiac transplantation in dilated cardiomyopathy?
End-stage heart failure
What is the characteristic feature of stress-induced cardiomyopathy?
Transient left ventricular dysfunction
What imaging modality is the standard for the diagnosis of hypertrophic cardiomyopathy?
Echocardiography
Which diagnostic test is primarily involved in the workup for Arrhythmogenic Right Ventricular Dysplasia (ARVD)?
Cardiac MRI
What is the primary management strategy for Arrhythmogenic Right Ventricular Dysplasia (ARVD) to prevent sustained ventricular arrhythmias and sudden death?
Implantable cardioverter-defibrillator (ICD) placement
What is the key characteristic of restrictive cardiomyopathy?
Non-dilated ventricles with impaired filling
What is the characteristic feature of Stress Cardiomyopathy (Takotsubo cardiomyopathy)?
Transient regional systolic dysfunction
What is the primary mechanism of sudden cardiac death in Hypertrophic Cardiomyopathy?
Ventricular arrhythmias
What is the primary cause of Arrhythmogenic Right Ventricular Dysplasia (ARVD)?
Genetic mutations
What triggers Stress Cardiomyopathy (Takotsubo cardiomyopathy)?
Intense emotional or physical stress
What is the primary treatment for symptomatic Hypertrophic Cardiomyopathy?
Beta-blockers
What is the mainstay treatment for restrictive cardiomyopathy?
Diuretics
What is the characteristic presentation of hypertrophic cardiomyopathy?
Asymmetrical septal hypertrophy
Study Notes
Cardiomyopathies: Key Facts and Definitions
- Cardiomyopathy is an abnormal cardiac muscle disease that can lead to heart failure and dysrhythmias
- Major types of cardiomyopathy include dilated, restrictive, hypertrophic, ARVD, and unclassified
- Conditions can manifest as one form of cardiomyopathy and progress to another, such as hypertensive heart disease starting with a hypertrophic pattern and progressing to dilated cardiomyopathy
- Incidence of cardiomyopathy is 5-10% of the 5-6 million patients in the US with heart failure, affecting people of all ages and races
- Etiology of cardiomyopathy can be inherited, acquired, or mixed, with risk factors including family history, ischemic heart disease, diabetes, and long-term alcoholism
- Presentation of cardiomyopathy can be asymptomatic or include symptoms such as shortness of breath, fatigue, edema, arrhythmia, and syncope
- Treatment goals for cardiomyopathy generally aim to slow down the disease, control symptoms, and prevent sudden death
- Dilated cardiomyopathy involves dilation and impaired contraction of one or both ventricles, often leading to impaired systolic function and heart failure
- Dilated cardiomyopathy has an epidemiology of 5-8/100k with a prevalence of 36/100k, and is the primary indication for cardiac transplantation
- Etiology of dilated cardiomyopathy is often unknown, with idiopathic cases comprising 50%, and myocarditis, ischemic heart disease, and other factors contributing to the rest
- Symptoms of dilated cardiomyopathy include progressive dyspnea, impaired exercise tolerance, orthopnea, paroxysmal nocturnal dyspnea, and peripheral edema
- Diagnosis of dilated cardiomyopathy involves echocardiogram, BNP, CXR, ECG, and cardiac catheterization, with treatment including addressing underlying causes, lifestyle changes, medications, and implantable devices like ICD and LVAD.
Cardiomyopathy: Restrictive, Arrhythmogenic, and Stress-Induced
- Restrictive cardiomyopathy is characterized by non-dilated ventricles with impaired ventricular filling and is caused by various conditions such as amyloidosis, connective tissue disorders, and hemochromatosis. It accounts for 5% of all cardiomyopathies.
- Its presentation includes progressive shortness of breath, exercise intolerance, and signs of heart failure, and diagnostics involve echocardiogram, CBC, and other tests specific to the underlying etiology.
- Treatment for restrictive cardiomyopathy is directed at the underlying cause, with mainstays being diuretics, vasodilators, and ACEIs, and implantables like pacemakers and heart transplantation.
- Arrhythmogenic Right Ventricular Dysplasia (ARVD) is a rare cardiomyopathy primarily affecting the right ventricle, caused by genetic mutations, and can lead to sudden cardiac arrest in young athletes.
- Symptoms of ARVD include dizziness, palpitations, syncope, and atypical chest pain, and workup involves EKG and echocardiogram to assess right ventricular function.
- Management of ARVD includes beta blockers, antiarrhythmics, radiofrequency ablation, and ICD placement to prevent sustained ventricular arrhythmias and sudden death.
- Stress cardiomyopathy, also known as Takotsubo cardiomyopathy, is a transient regional systolic dysfunction mostly affecting the left ventricle, mimicking myocardial infarction without obstructive coronary artery disease.
- It affects about 1-2% of patients with suspected acute coronary syndrome, predominantly older women, and is often triggered by intense emotional or physical stress.
- Presentation of stress cardiomyopathy is similar to acute coronary syndrome, with symptoms including chest pain, dyspnea, and signs of heart failure or arrhythmias.
- Diagnostics for stress cardiomyopathy involve ECG, troponin, BNP, and echocardiogram to detect left ventricular movement abnormalities.
- Diagnostic criteria for stress cardiomyopathy include transient LV systolic dysfunction, absence of obstructive coronary disease, new ECG abnormalities, or elevation in cardiac troponin.
- Overall, these diverse forms of cardiomyopathy have specific presentations, etiologies, and diagnostic and management strategies, emphasizing the importance of tailored approaches for each condition.
Cardiomyopathies: Restrictive, Arrhythmogenic Right Ventricular Dysplasia, and Stress Cardiomyopathy
- Restrictive Cardiomyopathy is characterized by non-dilated ventricles with impaired ventricular filling and typically absent hypertrophy, with some common etiologies including amyloidosis and connective tissue disorders.
- It accounts for 5% of all cardiomyopathies and has unique epidemiological patterns for different etiologies such as amyloidosis being more prevalent in males and females.
- The presentation of restrictive cardiomyopathy includes progressive shortness of breath, exercise intolerance, and signs of heart failure, and the diagnosis involves echocardiogram, laboratory tests, and imaging studies.
- Treatment for restrictive cardiomyopathy focuses on addressing the underlying cause, with mainstays including diuretics, vasodilators, and ACEIs, and in some cases, heart transplantation may be necessary.
- Arrhythmogenic Right Ventricular Dysplasia is a rare cardiomyopathy involving the replacement of right ventricle muscle tissue with fatty or fibrous tissue, often leading to conduction abnormalities and arrhythmias, with genetic mutations being the primary cause.
- Symptoms of Arrhythmogenic Right Ventricular Dysplasia include dizziness, palpitations, and syncope, and the workup involves EKG and echocardiogram, with the management focusing on heart failure and arrhythmias through various interventions.
- Stress Cardiomyopathy, also known as Takotsubo cardiomyopathy, is characterized by transient regional systolic dysfunction predominantly affecting the left ventricle, often triggered by intense emotional or physical stress.
- It affects around 1-2% of patients with suspected acute coronary syndrome, with a higher prevalence in older women, and the presentation is similar to acute coronary syndrome, with symptoms such as acute chest pain and dyspnea.
- Stress Cardiomyopathy can lead to signs of heart failure, tachyarrhythmias, and cardiogenic shock, and the diagnosis involves ECG abnormalities, elevated troponin and BNP, and echocardiogram to detect left ventricular movement abnormalities.
- The diagnostic criteria for Stress Cardiomyopathy include transient LV systolic dysfunction, absence of obstructive coronary disease, and new ECG abnormalities or elevated cardiac troponin.
- Stress Cardiomyopathy is theorized to be related to catecholamine excess, microvascular dysfunction, and genetic or psychiatric predispositions, and it is often triggered by intense emotional or physical stress.
- The management of Stress Cardiomyopathy involves addressing the underlying stress triggers, along with supportive care and monitoring for complications such as heart failure and arrhythmias.
Test your knowledge of cardiomyopathies with this quiz covering key facts and definitions. Explore the major types, etiology, symptoms, and treatment goals of this abnormal cardiac muscle disease that can lead to heart failure and dysrhythmias.
Make Your Own Quizzes and Flashcards
Convert your notes into interactive study material.
Get started for free
